Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.
about
Treatment with or without plasma exchange for patients with acquired thrombotic microangiopathy not associated with severe ADAMTS13 deficiency: a propensity score-matched study.Correlation between ADAMTS13 activity and neurological impairment in acute thrombotic microangiopathy patients.Thrombotic Microangiopathy Following Chemotherapy with S-1 and Cisplatin in a Patient with Gastric Cancer: A Case Report.Atypical Hemolytic Uremic Syndrome: A Brief Review.ADAMTS13 test and/or PLASMIC clinical score in management of acquired thrombotic thrombocytopenic purpura: a cost-effective analysis.Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency.Evaluating the impact of the ABO blood group on the clinical outcome of thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency.Does morphology matter in 2017? An approach to morphologic clues in non-neoplastic blood and bone marrow disorders.Thrombotic microangiopathies: a general approach to diagnosis and management.External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment.Dynamic changes in absolute immature platelet count suggest the presence of a coexisting immune process in the setting of thrombotic thrombocytopenic purpura.An Algorithmic Approach to the Diagnosis and Management of the Thrombotic Microangiopathies.Clinical characteristics and outcomes of thrombotic microangiopathy in Malaysia.Thrombotic thrombocytopenic purpura associated with dengue and chikungunya virus coinfection: case report during an epidemic period
P2860
Q33432547-C8D8DD12-0AC9-466A-BC66-7595351D8323Q33433636-11699DA6-9256-411B-A1D3-ACF5CBE02AFAQ33441312-9E7B34B5-7BCE-483D-927F-C9BCB8673768Q33442794-B7480140-E5C1-48DA-9D19-19DB812D3296Q38711023-6DF0DFA6-AA9A-471B-8833-10C7E921E937Q38716162-7A9D6DD5-52D6-426B-823A-69D1753B6A6EQ38736033-EC3B366A-7171-4E67-B629-14DA995C0300Q38817651-84169B21-4E59-47EA-8EE0-8F652464B493Q38984066-E6FBC8FC-511F-4093-9105-505F60469247Q47632660-739D0EDC-5D2B-48BA-BD03-5E45D4FB74DCQ47829141-16440E04-52AD-463B-A9BD-8813DF874B92Q50715554-26E359EE-FE37-4E5F-9C65-40D684B302C7Q55446927-92657EC4-FA50-4C2C-8C31-536AB3B1D39DQ58742196-9D759B88-71CC-49C4-BBFF-0895F9E4FD98
P2860
Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Impact of severe ADAMTS13 defi ...... rd TMA Research Collaborative.
@ast
Impact of severe ADAMTS13 defi ...... rd TMA Research Collaborative.
@en
type
label
Impact of severe ADAMTS13 defi ...... rd TMA Research Collaborative.
@ast
Impact of severe ADAMTS13 defi ...... rd TMA Research Collaborative.
@en
prefLabel
Impact of severe ADAMTS13 defi ...... rd TMA Research Collaborative.
@ast
Impact of severe ADAMTS13 defi ...... rd TMA Research Collaborative.
@en
P2093
P2860
P356
P1476
Impact of severe ADAMTS13 defi ...... rd TMA Research Collaborative.
@en
P2093
Ayad Hamdan
Christopher Stowell
Pavan K Bendapudi
Richard Kaufman
Robert S Makar
Walter Dzik
P2860
P304
P356
10.1111/BJH.13658
P407
P577
2015-08-28T00:00:00Z